Cardiovascular System

This group in Kalceks portfolio contains cardiac stimulants and antihypertensive medicines.

Products

Title
Furosemide injection
Strength 10 mg/ml
Volume 2 ml, 4 ml, 5 ml
ATC code C03CA01

Diuretic

Therapeutic indications
Indicated when no adequate diuresis is achieved with oral administration of furosemide or when oral use is not possible:
- oedemas and/or ascites secondary to cardiac or hepatic disorders
- oedemas secondary to renal disorders
- oedemas secondary to burns
- pulmonary oedema (e.g. in acute heart failure)
- supportive measure in cerebral oedema
- oliguria secondary to gestosis, if necessary after correction of a hypovolaemic state (NB: oedemas and/or hypertension in cases of gestosis are not an indication)
- hypertensive crisis (in addition to other therapeutic measures)

Levosimendan injection*
Strength 1.25 mg/ml, 2.5 mg/ml
Volume 1 ml
ATC code C01CX08

Cardiac simulants

Therapeutic indications
Indicated for the short-term treatment of acutely decompensated severe chronic heart failure (ADHF) in situations where conventional therapy is not sufficient, and in cases where inotropic support is considered appropriate.

*Under development

Norepinephrine injection
Strength 1 mg/ml
Volume 1 ml, 2 ml, 4 ml, 5 ml, 8 ml, 10 ml, 25 ml
ATC code C01CA03

CARDIAC STIMULANTS

Therapeutic indications
Recommended for use as an emergency measure in the restoration of blood pressure in cases of acute hypotension.

Urapidil injection
Strength 5 mg/ml
Volume 5 ml, 10 ml
ATC code C02CA06

ANTIHYPERTENSIVES

Therapeutic indications
Hypertensive emergencies (e.g. a critical rise in blood pressure), severe and very severe forms of hypertensive disease, hypertension resistant to treatment.
Controlled lowering of blood pressure in hypertensive patients during and/or after surgery.